KAM
ANAB icon

Krensavage Asset Management’s AnaptysBio ANAB Stock Holding History

Krensavage Asset Management’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-10,890
Closed -$282K – 14
2021
Q2 		$282K Sell
10,890
-14,800
-58% -$355K 0.1% 12
2021
Q1 		$554K Sell
25,690
-84,758
-77% -$2.14M 0.19% 11
2020
Q4 		$2.38M Sell
110,448
-8,410
-7% -$204K 0.69% 11
2020
Q3 		$1.75M Sell
118,858
-65,988
-36% -$1.19M 0.56% 11
2020
Q2 		$4.13M Sell
184,846
-259,031
-58% -$4.74M 1.12% 11
2020
Q1 		$6.27M Buy
443,877
+3,468
+0.8% +$52.6K 2.02% 12
2019
Q4 		$7.16M Buy
+440,409
New +$10.4M 2.44% 12

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Krensavage Asset Management's ANAB Position: Q3 2021 in Review

Krensavage Asset Management sold out of AnaptysBio (ANAB) in Q3 2021, closing a stake of 10,890 shares — an estimated $282K sold.

Krensavage Asset Management first reported a position in ANAB in Q4 2019 and held it in 7 quarters. The position peaked at $7.16M in Q4 2019. 127 funds tracked by Wall St. Rank hold ANAB as of Q3 2021.

  • Krensavage Asset Management reported no remaining AnaptysBio position as of Q3 2021 after selling out during the quarter.
  • Krensavage Asset Management sold 10,890 AnaptysBio shares in Q3 2021, an estimated $282K.
  • Krensavage Asset Management first reported a position in AnaptysBio in Q4 2019 and held it in 7 quarters.
  • Krensavage Asset Management's AnaptysBio position peaked at $7.16M in Q4 2019.
  • 127 funds tracked by Wall St. Rank held AnaptysBio as of Q3 2021.

Based on Krensavage Asset Management's 13F filing for Q3 2021, filed 16 Nov 2021.